PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPTIN AS AN ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS FROM THE BRAZILIAN PRIVATE HEALTH SYSTEM
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72120-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)72120-9/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
279
First Page :
A295
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72120-9&doi=10.1016/S1098-3015(11)72120-9